TARDBP and Alzheimer disease: In the present study, we aimed to measure expression of TDP-43 in patients with AD by isolating and analyzing plasma NDEs, and to further explore the association between TDP-43 and cognitive function, neuropsychiatric symptoms and APOE genotype.